Written by mojotech | Jun 8, 2018 4:00:00 AM
June 7, 2018 -
Craig Hemenway and
Paul Prendergast, shareholders in Brownstein Hyatt Farber Schreck’s Denver office, were named in this year’s
Intellectual Asset Magazine (IAM) Patent 1000 Rankings. These attorneys, as well as the firm, are recognized by IAM for their work in patent prosecution. Every year, IAM compiles a list of the top 1000 patent attorneys in the world and breaks it down by country and U.S. state, recommending those considered leaders in the field. The process involves extensive international research including interviews with more than 1,500 individuals to gather feedback from peers and clients with knowledge of the attorneys’ practices and markets. This year’s ranking commentary IAM states, “Brownstein Hyatt Farber Schreck keeps some of the most demanding and innovative technology companies happy by providing creative, commercially driven solutions to patent problems informed by profound product and sector knowledge.” Brownstein’s IP Group handles trademarks, patents, counseling and submission, technology issues and intellectual property as it applies to corporate transactions. These attorneys help clients realize the full value of intellectual property rights through licensing agreements, joint ventures and development strategies and guide clients through product development as well as any issue associated with the acquisition, enforcement and exploitation of intellectual property. Brownstein’s lead patent attorney for high tech matters, Hemenway has been recognized by IAM each year since 2014 for both prosecution and transactions. He works with both startups and major corporations, including a Fortune 50 technology client, providing strategic counseling, managing complex portfolios of patent assets, advising on complex IP transactions, licensing IP assets, and providing opinions of counsel. He is a former control systems engineer with deep experience in both patent law and engineering.
Prendergast has been ranked since 2014, and is a patent attorney focusing on life science and chemical issues in the areas of patent prosecution, strategic patent portfolio advice, reexaminations, clearance counseling, diligence analysis, opinion counsel and post grant proceedings. His experience spans various aspects of intellectual property law, including U.S. and foreign patent prosecution, freedom to operate opinions, infringement and validity opinions, licensing agreements, and overall due diligence reviews.